EPISODE · Aug 30, 2024 · 6 MIN
An Analysis From the SELECT Trial - COVID-19| ESC 2024
from JACC This Week
Harlan Krumholz, MD, FACC, JACC Editor-in-Chief, and Benjamin M. Scirica, MD, MPH, FACC, discuss the surprising benefits of semaglutide beyond weight loss and cardiovascular health from the SELECT trial, which investigated the effects of semaglutide on COVID-19 outcomes and non-cardiovascular deaths in patients with obesity and cardiovascular disease.
Embed this episode
NOW PLAYING
An Analysis From the SELECT Trial - COVID-19| ESC 2024
0:00
6:50
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JACC This Week?
This episode is 6 minutes long.
When was this JACC This Week episode published?
This episode was published on August 30, 2024.
Can I download this JACC This Week episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!